Thomas Steyer’s Cardinal Health CAH Stock Holding History

Thomas Steyer’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-368,000	Closed	-$77.8M	–	104
2026 Q1	$77.8M	Sell	368,000 -208,000	-36%	-$44.8M	0.41%	37
2025 Q4	$118M	Buy	576,000 +323,000	+128%	+$60.8M	0.51%	44
2025 Q3	$39.7M	Sell	253,000 -201,000	-44%	-$31M	0.16%	61
2025 Q2	$76.3M	Buy	454,000 +181,000	+66%	+$26.9M	0.32%	49
2025 Q1	$37.6M	Buy	+273,000	New	+$34.8M	0.18%	62

Other funds holding CAH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Thomas Steyer's CAH Position: Q2 2026 in Review

Thomas Steyer sold out of Cardinal Health (CAH) in Q2 2026, closing a stake of 368,000 shares — an estimated $77.8M sold.

Thomas Steyer first reported a position in CAH in Q1 2025 and held it in 5 quarters. The position peaked at $118M in Q4 2025. 1,490 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

Thomas Steyer reported no remaining Cardinal Health position as of Q2 2026 after selling out during the quarter.
Thomas Steyer sold 368,000 Cardinal Health shares in Q2 2026, an estimated $77.8M.
Thomas Steyer first reported a position in Cardinal Health in Q1 2025 and held it in 5 quarters.
Thomas Steyer's Cardinal Health position peaked at $118M in Q4 2025.
1,490 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Farallon Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.